Atypical protein kinase C phosphorylates IKKalphabeta in transformed non-malignant and malignant prostate cell

Hla Y Win1, Mildred Acevedo-Duncan

  • 1Department of Chemistry, University of South Florida, James A. Haley Veteran Hospital, 13000 Bruce B. Downs Blvd. VAR 151, Tampa, FL 33612, USA.

Cancer Letters
|June 24, 2008
PubMed

Insights

Atypical protein kinase C-iota (aPKC-iota) activation by tumor necrosis factor alpha (TNFalpha) influences the NF-kappaB pathway in prostate cells. This suggests aPKCs may regulate NF-kappaB signaling in prostate cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Atypical protein kinase C-iota (aPKC-iota) plays a role in cell survival and proliferation, making it a target in various cancers.
  • The NF-kappaB pathway is crucial in inflammation and cancer, and its regulation is of significant interest.

Purpose of the Study:

  • To investigate the role of aPKC-iota in the NF-kappaB pathway activation in prostate cancer cells treated with tumor necrosis factor alpha (TNFalpha).

Main Methods:

  • Prostate cancer cell lines (DU-145, RWPE-1, LNCaP) were treated with TNFalpha.
  • Western blotting and immunofluorescence were used to analyze protein phosphorylation, degradation, and nuclear translocation.

Main Results:

  • DU-145 cells showed TNFalpha-induced PKC-iota phosphorylation of IKKalphabeta, while RWPE-1 cells showed PKC-zeta involvement.
  • IkappaBalpha degradation and NF-kappaB/p65 nuclear translocation occurred in all cell lines.
  • LNCaP cells exhibited weak IKKalpha activation, with no observed upstream aPKC phosphorylation of IKKalphabeta.

Conclusions:

  • aPKCs may be involved in the activation of the NF-kappaB pathway in prostate cancer cells.
  • Differential roles of aPKC-iota and aPKC-zeta in TNFalpha-induced NF-kappaB signaling were observed across different prostate cell lines.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...